About
In Silico Drug Discovery
Areas of Focus
Categories
Contract ResearchContract ResearchContract ResearchContract Research
Team (2)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
191
By Phase
PHASE1: 2PHASE2: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05701644Lead Sponsor
Study To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects
PHASE1Completed
36 participants
Started: Jan 2, 2023 · Completed: Jun 28, 2023
NCT05980065Collaborator
To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects
PHASE1Completed
35 participants
Started: Dec 20, 2022 · Completed: Oct 4, 2023
NCT05697952Lead Sponsor
E1K Intra Articular(IA) Treatment for Knee Osteoarthritis
PHASE2Completed
120 participants
Started: Jun 13, 2022 · Completed: Nov 29, 2023
Locations (1)
Headquarters
Daejeon, Korea
Map
Loading map...